Literature DB >> 31853684

The (ir)relevance of the abandoned criterion II for the diagnosis of serrated polyposis syndrome: a retrospective cohort study.

Arne G C Bleijenberg1, Joep E G IJspeert1, Daniel Rodríguez-Alcalde2, Sabela Carballal3, Maurits R Visser1, Maria Pellise3, Jan Jacob Koornstra4, Salman A Rana5,6, Andrew Latchford5,6, Francesc Balaguer3, Evelien Dekker7.   

Abstract

The World Health Organization (WHO) recently updated the diagnostic criteria for serrated polyposis syndrome (SPS). One of the three previous diagnostic criteria (criterion II2010) is now abandoned: ≥ 1 serrated polyp (SP) proximal to the sigmoid in a first-degree relative (FDR) of a patient with SPS. Individuals fulfilling this abandoned criterion now receive the same surveillance recommendations as all FDRs of patients with SPS. We aimed to compare the incidence of advanced neoplasia (AN) in FDRs with vs. without fulfillment of the abandoned criterion II2010. We retrospectively recruited FDRs of patients with SPS who underwent a colonoscopy, and stratified them according to fulfilment of criterion II2010 at baseline. Our primary and secondary outcomes were AN incidence during surveillance and at baseline, respectively. We included 224 FDRs of patients with SPS, of whom 36 (16%) fulfilled criterion II2010 at baseline. One hundred and five underwent surveillance after baseline. Criterion II2010-positive FDRs were at increased risk of AN, both during surveillance (hazard ratio 8.94, 95% CI 2.15-37.1, p = .003) as well as at baseline (adjusted odds-ratio 9.30, 95% CI 3.7-23.3, p < .001). FDRs of patients with SPS that underwent colonoscopy and fulfilled the abandoned criterion II2010 for SPS diagnosis were at increased risk of AN at baseline and during surveillance in this small, retrospective cohort study. Our results should be interpreted with caution but suggest that adherence to surveillance recommendations for all FDRs of patients with SPS is important, especially for those that would have fulfilled the now abandoned criterion II2010.

Entities:  

Year:  2020        PMID: 31853684     DOI: 10.1007/s10689-019-00156-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  19 in total

1.  Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview.

Authors:  J E G IJspeert; R Bevan; C Senore; M F Kaminski; E J Kuipers; A Mroz; X Bessa; P Cassoni; C Hassan; A Repici; F Balaguer; C J Rees; E Dekker
Journal:  Gut       Date:  2016-02-24       Impact factor: 23.059

2.  The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps.

Authors:  Joep E G IJspeert; Sascha C van Doorn; Ymkje M van der Brug; Barbara A J Bastiaansen; Paul Fockens; Evelien Dekker
Journal:  Gastrointest Endosc       Date:  2015-04-29       Impact factor: 9.427

3.  Sessile Serrated Adenomas in Young Patients may have Limited Risk of Malignant Progression.

Authors:  Mark Bettington; Ian Brown; Christophe Rosty; Neal Walker; Cheng Liu; John Croese; Tony Rahman; Sally-Ann Pearson; Diane McKeone; Barbara Leggett; Vicki Whitehall
Journal:  J Clin Gastroenterol       Date:  2019-03       Impact factor: 3.062

4.  Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome.

Authors:  K S Boparai; J B Reitsma; V Lemmens; T A M van Os; E M H Mathus-Vliegen; J J Koornstra; F M Nagengast; L P van Hest; J J Keller; E Dekker
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

5.  Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy.

Authors:  Charles J Kahi; David G Hewett; Dustin Lee Norton; George J Eckert; Douglas K Rex
Journal:  Clin Gastroenterol Hepatol       Date:  2010-10-01       Impact factor: 11.382

6.  Yield of screening colonoscopy in first-degree relatives of patients with serrated polyposis syndrome.

Authors:  Yark Hazewinkel; Jan-Jacob Koornstra; Karam S Boparai; Theo A M van Os; Kristien M A J Tytgat; Susanne Van Eeden; Paul Fockens; Evelien Dekker
Journal:  J Clin Gastroenterol       Date:  2015 May-Jun       Impact factor: 3.062

7.  Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.

Authors:  Sabela Carballal; Daniel Rodríguez-Alcalde; Leticia Moreira; Luis Hernández; Lorena Rodríguez; Francisco Rodríguez-Moranta; Victoria Gonzalo; Luis Bujanda; Xavier Bessa; Carmen Poves; Joaquin Cubiella; Inés Castro; Mariano González; Eloísa Moya; Susana Oquiñena; Joan Clofent; Enrique Quintero; Pilar Esteban; Virginia Piñol; Francisco Javier Fernández; Rodrigo Jover; Lucía Cid; María López-Cerón; Miriam Cuatrecasas; Jorge López-Vicente; Maria Liz Leoz; Liseth Rivero-Sánchez; Antoni Castells; María Pellisé; Francesc Balaguer
Journal:  Gut       Date:  2015-08-11       Impact factor: 23.059

8.  Serrated adenomatous polyposis in humans.

Authors:  E Torlakovic; D C Snover
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

9.  Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

Authors:  J E G IJspeert; S A Q Rana; N S S Atkinson; Y J van Herwaarden; B A J Bastiaansen; M E van Leerdam; S Sanduleanu; T M Bisseling; M C W Spaander; S K Clark; G A Meijer; N van Lelyveld; J J Koornstra; I D Nagtegaal; J E East; A Latchford; E Dekker
Journal:  Gut       Date:  2015-11-24       Impact factor: 23.059

10.  Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.

Authors:  Rune Erichsen; John A Baron; Stephen J Hamilton-Dutoit; Dale C Snover; Emina Emilia Torlakovic; Lars Pedersen; Trine Frøslev; Mogens Vyberg; Stanley R Hamilton; Henrik Toft Sørensen
Journal:  Gastroenterology       Date:  2015-12-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.